M
Masafumi Kuramoto
Researcher at Kumamoto University
Publications - 45
Citations - 760
Masafumi Kuramoto is an academic researcher from Kumamoto University. The author has contributed to research in topics: Cancer & Metastasis. The author has an hindex of 10, co-authored 45 publications receiving 713 citations.
Papers
More filters
Journal Article
Immunoreactive Hepatocyte Growth Factor Is a Strong and Independent Predictor of Recurrence and Survival in Human Breast Cancer
Jun-ichi Yamashita,Michio Ogawa,Shin-ichi Yamashita,Koichi Nomura,Masafumi Kuramoto,Tetsushi Saishoji,Sadahito Shin +6 more
TL;DR: In multivariate analysis, ir-HGF level was found to be the most important independent factor in predicting relapse-free and overall survival, of greater import than lymph node involvement.
Journal ArticleDOI
Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.
Masafumi Kuramoto,Shinya Shimada,Satosi Ikeshima,Akinobu Matsuo,Yasushi Yagi,Masakazu Matsuda,Yutaka Yonemura,Hideo Baba +7 more
TL;DR: It is revealed that EIPL-IPC therapy significantly improved the 5-year survival span of advanced gastric cancer patients with CY+/P− and is strongly recommended as a standard prophylactic strategy for peritoneal dissemination.
Journal ArticleDOI
Second-line chemotherapy with combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fluorouracil.
TL;DR: Based on its remarkable effectiveness, marked improvement in the quality of life of the patients, and the convenience of its administration, the I/low-P regimen is recommended as a promising second-line chemotherapeutic regimen for patients with metastatic gastric cancer resistant to 5-FU.
Journal Article
Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 Study).
Toru Beppu,Yasunori Emi,Shoji Tokunaga,Eiji Oki,Ken Shirabe,Shinichi Ueno,Masafumi Kuramoto,Akira Kabashima,Ikuo Takahashi,Hironori Samura,Susumu Eguchi,Yoshito Akagi,Shoji Natsugoe,Yutaka Ogata,Yoshihiro Kakeji,Hideo Baba,Yoshihiko Maehara +16 more
TL;DR: In this article, the authors conducted a phase II trial concerning liver resectability after first-line treatment of advanced liver-limited colorectal metastases (CRLM) by a prospective, multi-center study.
Journal ArticleDOI
A Proposal of a Practical and Optimal Prophylactic Strategy for Peritoneal Recurrence
Masafumi Kuramoto,Shinya Shimada,Satoshi Ikeshima,Akinobu Matsuo,Hiroshi Kuhara,Kojiro Eto,Hideo Baba +6 more
TL;DR: EIPL therapy is verified as an optimal and standard prophylactic therapeutic strategy for peritoneal recurrence and its potential as a useful and practical adjuvant surgical technique is verified.